Cargando…
Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
SIMPLE SUMMARY: The nomogram derived from the pivotal phase III NAPOLI-1 study could predict the overall survival in gemcitabine-refractory metastatic pancreatic cancer treated with liposomal irinotecan plus fluorouracil and leucovorin. However, the NAPOLI-1 nomogram has not been validated in a real...
Autores principales: | Su, Yung-Yeh, Chiang, Nai-Jung, Yang, Yi-Hsin, Yen, Chia-Jui, Bai, Li-Yuan, Chiu, Chang-Fang, Chuang, Shih-Chang, Yang, Shih-Hung, Chou, Wen-Chi, Chen, Jen-Shi, Chiu, Tai-Jan, Chen, Yen-Yang, Chan, De-Chuan, Peng, Cheng-Ming, Chiu, Sz-Chi, Li, Chung-Pin, Shan, Yan-Shen, Chen, Li-Tzong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954707/ https://www.ncbi.nlm.nih.gov/pubmed/36831353 http://dx.doi.org/10.3390/cancers15041008 |
Ejemplares similares
-
Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study
por: Su, Yung-Yeh, et al.
Publicado: (2022) -
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
por: Chiu, Tai-Jan, et al.
Publicado: (2021) -
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study
por: Bang, Yung‐Jue, et al.
Publicado: (2019) -
Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan
por: Chen, Chia-Yu, et al.
Publicado: (2020) -
Multicentre, phase II study of gemcitabine and S‐1 in patients with advanced biliary tract cancer: TG1308 study
por: Chiang, Nai‐Jung, et al.
Publicado: (2020)